author-photo

Sreeni Chittoor

Texas Oncology

6

Papers

165

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

2013 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (59)
Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (58)
Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.

2006 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Phase II study of low dose (weekly) docetaxel and estramustine in elderly males (age >=75 years) with hormone-refractory prostate cancer or patients age 18 to 74 years with an ECOG performance status of 2 or 3

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
A planned comparison of menopausal symptoms during year 1 in patients receiving either exemestane or tamoxifen in a double-blind adjuvant hormonal study

2003
Show All
- Source
- Cite
- Save
Citations (8)
Sticky Platelet Syndrome: A Case Report and Review of the Literature

1998 Clinical and Applied Thrombosis-Hemostasis
Show All
- Source
- Cite
- Save
Citations (28)